Today's press release is incredibly important.
Post# of 72440
They needed to come up with a powdered formulation they could use for the OM sachets. They wouldn't be signing this contract if they hadn't figured out how to do it.
When they have the powder and package it in the sachets, they can do the next Brilacidin-OM clinical trial. If the results are as great with this formulation as they were with the pre-mixed stuff, it could lead to very fast FDA approval.
This is a big step forward in the progress of the company.